Plasmablastic Lymphoma

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma [Phase 1]

  A Phase 1 study evaluating Teclistamab in patients with recurrent or refractory plasmablastic lymphoma; the trial status is NOT_YET_RECRUITI…

• CLINICAL_TRIALS research · 2026-03-18
  Clinical Trial Update: Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease [Phase 2]

  A National Cancer Institute-supported Phase 2 trial evaluating daratumumab in relapsed/refractory primary effusion lymphoma, plasmablastic l…

• CLINICAL_TRIALS research · 2026-02-19
  Clinical Trial Update: Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas [Phase 1]

  Phase 1 trial evaluating pomalidomide with dose-adjusted EPOCH, with or without rituximab, for HIV-associated lymphomas; recruitment is ongo…

• CLINICAL_TRIALS research · 2025-12-24
  Clinical Trial Update: Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. [Phase 2]

  Phase 2 clinical trial evaluating a combination of daratumumab, bortezomib, and dexamethasone in patients with plasmablastic lymphoma. The s…

• CLINICAL_TRIALS research · 2025-12-02
  Clinical Trial Update: Study on Plasmablastic Lymphoma Patients

  A clinical trial update indicates a study on plasmablastic lymphoma sponsored by Fondazione Italiana Linfomi is currently recruiting. No res…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-07-17
  Clinical Trial Update: Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  AIDS Malignancy Consortium is recruiting for a study to collect blood and tissue samples from participants with HIV/AIDS-related cancers to …